by Brian Hunt | Apr 12, 2022 | News, Radiation Dermatitis
What is Radiation Dermatitis and what causes it? Modern radiation therapy (RT) utilizes a series of small doses of ionizing radiation to kill cancer cells and shrink tumors. Your health care provider’s goal with this therapy is to kill tumor cells after repeated...
by Brian Hunt | Mar 18, 2022 | News
Winston-Salem, N.C., March 18, 2022 – KeraNetics Inc. announced today that it has been awarded a contract in the amount of $3.5 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for...
by Brian Hunt | Jan 20, 2022 | News, Radiation Dermatitis
Radiation burn, or radiation dermatitis, can be a side effect of radiotherapy treatments for cancer. It is estimated that more than 90% of the 4 million Americans receiving radiation therapy treatments will develop radiation burn or radiation dermatitis. Symptoms...
by Brian Hunt | Jan 6, 2022 | News
Livability Magazine recently highlighted KeraNetics™ as one of the leading bioscience companies in Winston-Salem. KeraNetics™ was highlighted for its bioscience advancements on treating and managing radiation burns. Additionally, FDA approval for our KeraStat® Cream...
by Brian Hunt | Dec 9, 2021 | News, Radiation Dermatitis
Radiation dermatitis (RD) refers to a spectrum of skin reactions that may occur as a result of radiation therapy. Around 85 percent of cancer patients who undergo radiation therapy experience moderate to severe skin reactions. These reactions can be a frustrating and...
by Brian Hunt | Dec 2, 2021 | News
A recent report by DelveInsight projects that the market for burn treatments, including treatments for radiation burns and management of radiation dermatitis, will grow 1.96% annually from 2018 to 2030. Advancements in burn care treatments and products, such as...
Recent Comments